Premier Alternatives

EnteroBiotix

Bellshill, United Kingdom · Founded 2017 · Privately Held (backing)

Developer of microbiome-modulating drugs designed to restore health and prevent bacterial infections. EnteroBiotix is based in Bellshill, United Kingdom and was founded in 2017. Its last reported valuation was $66.8 million in Mar 2024. It has raised $94.2 million across 6 recorded rounds; the latest was a $5.3 million early-stage round in Mar 2026.

Last reported valuation
$66.8M
Oct 2026
Priced at
—
Total raised
$94.2M
Last round
Early Stage VC
Mar 2026

EnteroBiotix key facts

as of Oct 2026
  • Developer of microbiome-modulating drugs designed to restore health and prevent bacterial infections.
  • EnteroBiotix is valued at approximately $66.8M as of Oct 2026 (last reported valuation).
  • It has raised $94.2M across 6 recorded rounds; the latest was Early Stage VC ($5.3M) in Mar 2026.
  • Notable investors include Innovate UK, Scottish Enterprise, SyndicateRoom, The Scottish National Investment Bank, Bank Workers Charity — 20 tracked in total.
  • EnteroBiotix has filed 5 Form Ds with the SEC since 2022, most recently Jul 2025 ($1.4M sold to 2 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$66.8M

EnteroBiotix's last reported valuation, Mar 2024. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of EnteroBiotix with a free account
  • ·The complete investor list: 20 names
  • ·Watch EnteroBiotix: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

EnteroBiotix funding rounds

6 rounds
Mar 2026Early Stage VC$5.3MSEC filing▮
Jul 2025Seed Round$1.4MSEC filing▮
Mar 2024Seed Round$1.3MSEC filing▮
Jan 2024Seed Round$2.6MSEC filing▮
Aug 2023Early Stage VC$6.7MSEC filing▮
Full funding history →

EnteroBiotix valuation

EnteroBiotix's last reported valuation was $66.8 million in Mar 2024. No priced round, secondary trade or fund mark has surfaced since.

How much has EnteroBiotix raised?

EnteroBiotix has raised $94.2 million in total; 6 of its rounds are on record, from 2022 on. The largest on record was a $6.7 million early-stage round in Aug 2023; the most recent was a $5.3 million early-stage round in Mar 2026.

EnteroBiotix has filed 5 Form Ds with the SEC since 2022, most recently in Jul 2025 ($1.4 million sold to 2 investors).

EnteroBiotix investors

20 investors are on record for EnteroBiotix, including Innovate UK, Scottish Enterprise, SyndicateRoom and The Scottish National Investment Bank. The early-stage round in Mar 2026 drew 6 investors.

About EnteroBiotix

Developer of microbiome-modulating drugs designed to restore health and prevent bacterial infections. The company focuses on creating microbial therapeutics for patients with serious unmet medical needs and addresses them through a pipeline of tailored, high-diversity products that fortify and restore the microbiome, enabling physicians to prevent and treat debilitating infections and diseases.

Sector
Healthcare
HQ
Bellshill, United Kingdom
Founded
2017
Employees
49
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.